F

4D Molecular Therapeutics
D

FDMT

8.63500
USD
-1.37
(-13.65%)
مغلق
حجم التداول
26,282
الربح لكل سهم
-4
العائد الربحي
-
P/E
-3
حجم السوق
451,405,453
المقالات
المزيد

العنوان: 4D Molecular Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).